HARBOUR INVESTMENTS, INC.

Position in ARWR — Arrowhead Pharmaceuticals, Inc.

CIK 810121 MADISON, WI

Position in ARWR

as of Jun 30, 2026 · filed Aug 12, 2026 Compact

Position Value

$42,548

+$10,509 QoQ

Shares Held

522

+2.2% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#413

of 497 holders

Holding Since

Mar 2021

13 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

HARBOUR INVESTMENTS, INC. holds $3,692,478 across 135 Biotechnology names. ARWR ranks #17 (1.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VKTX	Viking Therapeutics, Inc.	16,451	$641,753
2	REGN	Regeneron Pharmaceuticals, Inc.	636	$396,571
3	VRTX	Vertex Pharmaceuticals Inc / Ma	734	$364,599
4	JAZZ	Jazz Pharmaceuticals plc	1,365	$328,924
5	OMER	Omeros Corp	23,139	$220,051
6	CRSP	CRISPR Therapeutics AG	3,533	$192,689
7	STOK	Stoke Therapeutics, Inc.	4,413	$144,393
8	NTLA	Intellia Therapeutics, Inc.	7,534	$127,475

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$42,548	522	+2.2%	Shares	Sole	2026-08-12
2026-03-31	$32,039	511	+176.2%	Shares	Sole	2026-05-15
2025-12-31	$12,282	185	+1.6%	Shares	Sole	2026-02-09
2025-09-30	$6,277	182	+574.1%	Shares	Sole	2025-11-12
2025-06-30	$426	27	0.0%	Shares	Sole	2025-07-28
2025-03-31	$343	27	0.0%	Shares	Sole	2025-05-08
2024-12-31	$507	27	-82.0%	Shares	Sole	2025-02-10
2024-09-30	$2,905	150	-57.1%	Shares	Sole	2024-11-04
2024-06-30	$9,096	350	0.0%	Shares	Sole	2024-07-26
2024-03-31	$10,010	350	-66.3%	Shares	Sole	2024-07-22
2021-09-30	$64,927	1,040	-7.8%	Shares	Sole	2021-11-15
2021-06-30	$93,420	1,128	+0.1%	Shares	Sole	2021-08-16
2021-03-31	$74,731	1,127	—	Shares	Sole	2021-08-17
No filing history on record for this holder in this stock.